fda enforcement actions bpc-157 BPC-157: The Real Reason Why It's Not Approved BPC-157 Before the FDA: Briefing
Description
By blocking NNMT activity, it increases critical cellular metabolites (SAM, NAD) that drive downstream increases in energy expenditure and metabolic health 1-4
The pain is relieved by sitting or leaning forward (the shopping cart sign)
Discontinue use if irritation persists
It antagonizes amphetamine-induced anxiety in animal models, suggesting protective effects against stimulant-driven mood disturbances
